DiaMedica Therapeutics Earning Date (DMAC)

USA |NASDAQ |USD

DMAC Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Mar 8, 2022 Dec 2021 $-0.18 $-0.18 $-0.23
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Mar 8, 2022 Dec 2021 $0.00 $0.00 $0.00

Diamedica Therapeutics's next earnings date is Tuesday, Mar 8, 2022 for the fiscal quarter ending Dec 2021.

DMAC Earnings Date & History Chart

DMAC Earnings & Revenue Forecast

DMAC Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.18 $-0.22 $-0.14
Mar 2022 3 $-0.25 $-0.32 $-0.19
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $-0.73 $-0.76 $-0.68
Dec 2022 5 $-1.01 $-1.27 $-0.72

DMAC Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-0.23 $-0.23 $-0.30
Mar 2022 2 / 0 $-0.30 $-0.30 $-0.35
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2021 4 / 0 $-0.83 $-0.83 $-0.91
Dec 2022 4 / 0 $-1.13 $-1.13 $-1.32

DMAC Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Mar 2022 3 $0.00 $0.00 $0.00
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2021 5 $0.00 $0.00 $0.00
Dec 2022 5 $0.00 $0.00 $0.00

DMAC Earnings Date & Revenue History

DMAC Earnings History

|
Show More
Show More

DMAC Revenue History

|
Show More
Show More

Diamedica Therapeutics Next Earnings Date & Report

DMAC Next Earnings Date & Report Preview: Dec 2021 (FQ)

DMAC's next earnings date is Tuesday, Mar 8, 2022 for the fiscal quarter ending Dec 31, 2021.

According to 5 analysts, the average EPS estimation for Diamedica Therapeutics's next quarterly earnings is $-0.18, with a low EPS estimation of $-0.22, and a high estimation of $-0.14.

Over the last 1 month, EPS estimates have seen 4 upward revisions and 0 downward. The EPS 1 month trend is $-0.23, the last 2 month trend is $-0.23, and the 3 month trend is $-0.30.

Based on 5 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.

Diamedica Therapeutics Previous Earnings Dates & Reports

DMAC Previous Earnings Date & Report Recap: Sep 2021 (FQ)

Diamedica Therapeutics's previous earnings date was Nov 10, 2021 for its fiscal quarter ended Sep 30, 2021.

DMAC's earnings per share (EPS) was $-0.18, beating the consensus analysts forecast of $-0.23 by 22.58%.

The EPS was lower than the previous fiscal quarter (Jun 2021) by 5.88%, and higher than the same period a year before (Sep 2020) by -5.26%.

Revenues were $0.00.

The company reported a net income of $-3.45M.

Free cash flow for the quarter was $-3.05M , compared to $-2.09M last quarter and $-2.35M a year before.

DMAC ended the quarter with $68.00K in total debt, a decrease of -20.00% compared to the previous quarter, and a decrease of -49.25% compared to the same quarter a year before.

DMAC Previous Earnings Date & Report Recap: Dec 2020 (FY)

Diamedica Therapeutics's previous annual earnings date was Mar 10, 2021 for its fiscal year ended Dec 31, 2020.

DMAC's earnings per share (EPS) was $-0.78.

Revenues were $0.00.

The company reported a net income of $-12.29M.

Diamedica Therapeutics reported a free cash flow of $-9.23M for its fiscal year, compared to $-9.10M a year ago.

The company ended the fiscal year with $72.00K in total debt, a decrease of -59.55% compared to the previous year.